Ads
related to: Prostate Cancer Treatment
Search results
Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?
Motley Fool via Yahoo Finance· 11 minutes agoMore recent positive phase 3 results for Cabometyx include metastatic castration-resistant prostate ...
Mission Possible: Researching nanobubbles to better fight cancer
WKYC Cleveland· 1 hour agoCase Western Reserve University has over a decade of research into an innovative way to detect and...
Radiotherapy with hormone therapy can help some advanced prostate cancer patients avoid chemotherapy
Medical Xpress· 3 days agoOligoprogressive cancer occurs when cells from the original tumor travel within the body to fewer...
MemorialCare Cancer Institute Revolutionizes Prostate Cancer Treatment: Hot Water Potential Solution...
WFRV 5 Green Bay· 5 days agoMemorialCare Cancer Institute at Saddleback Medical Center is the only location in Orange County – and one of only two in California – to offer a new, innovative way to treat ...
Ask Amy: I don’t want to be defined by cancer diagnosis, nor keep it secret
The Republican· 3 days agoLiving with — not dying of — cancer means a few lifestyle changes and the need to be more aware of...
Hospital is first in WNY to offer noninvasive prostate cancer therapy
WGRZ-TV Buffalo· 2 days agoPerformed noninvasively in the outpatient setting under general anesthesia, HIFU uses focal therapy...
Everything we know about King Charles' cancer, from diagnosis to treatment
TODAY via Yahoo News· 4 days agoKing Charles III has just made his first public engagement at a London hospital since Buckingham...
...DO, FACOI, FACP is Lead Author of Case Study Demonstrating Importance of Genomic Testing in Early...
NBC 17 Raleigh· 5 days agoInherited genetic mutations are known to increase risk for many forms of cancer in women and men.
Johnson & Johnson reports data from Phase II prostate cancer trial
Clinical Trials Arena via Yahoo Finance· 6 days agoJohnson & Johnson Innovative Medicine Solid Tumor Medical Affairs vice-president Luca Dezzani said:...
Fusion Pharmaceuticals doses first subject in prostate cancer trial
Clinical Trials Arena via Yahoo Finance· 2 days agoFPI-2265 is an actinium-225-based prostate-specific membrane antigen (PSMA) targeting radioconjugate...